MARIA SONIA GAZTAMBIDE SAENZ-rekin lankidetzan egindako argitalpenak (9)

2021

  1. E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment

    Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887

2009

  1. Exploring the diabetogenicity of the HLA-B18-DR3 CEH: Independent association with T1D genetic risk close to HLA-DOA

    Genes and Immunity, Vol. 10, Núm. 6, pp. 596-600

2007

  1. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 6, pp. 2370-2373

  2. Mutations in GCK and HNF-1α explain the majority of cases with clinical diagnosis of MODY in Spain

    Clinical Endocrinology, Vol. 67, Núm. 4, pp. 538-546

2006

  1. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease

    Genes and Immunity, Vol. 7, Núm. 7, pp. 550-554

2001

  1. An Infrequent Double Mutation in the MEN1 Gene

    International Journal on Disability and Human Development, Vol. 2, Núm. 4, pp. 241-246

  2. An infrequent double mutation in the MEN1 gene

    Journal of Endocrine Genetics, Vol. 2, Núm. 4, pp. 241-246

2000

  1. Excess iron storage in patients with type 2 diabetes unrelated to primary hemochromatosis [5]

    New England Journal of Medicine

1998

  1. Identification of a novel nonsense mutation and a missense substitution in the vasopressin-neurophysin II gene in two Spanish kindreds with familial neurohypophyseal diabetes insipidus

    Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 3, pp. 995-997